Inducible Nitric Oxide Synthase-Vascular Endothelial Growth Factor Axis: A Potential Target to Inhibit Tumor Angiogenesis by Dietary Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|7|5|475-483

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.5, 2007-08, pp. : 475-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis

By  

Current Cancer Drug Targets, Vol. 12, Iss. 1, 2012-01 ,pp. : 23-43

Bentham Science Publishers

Access to resources Recommend Favorite

The inducible nitric oxide synthase in vascular and cardiac tissue

By Stoclet J.-C.   Muller B.   Gyorgy K.   Andriantsiothaina R.   Kleschyov A.L.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 139-155

Elsevier

Access to resources Recommend Favorite

Inducible Nitric Oxide Synthase as a Possible Target in Hypertension

By  

Current Drug Targets, Vol. 15, Iss. 2, 2014-02 ,pp. : 164-174

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Inhibitors of Inducible Nitric Oxide Synthase: Potential Agents for the Treatment of Inflammatory Diseases?

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-01 ,pp. : 77-92

Bentham Science Publishers

Access to resources Recommend Favorite

Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation

By Hattori Y.   Hattori S.   Kasai K.  

European Journal of Pharmacology, Vol. 481, Iss. 2, 2003-11 ,pp. : 153-158

Elsevier

Access to resources Recommend Favorite